Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Life changes impact budgeting in many ways. This intro shows how to anticipate shifts, recalibrate goals, and keep your finances stable.
22,101 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
The U.S.-led airstrike on Iran sent markets into a tailspin, with oil surging and stock indexes dropping. As policyma...
Fintech down this year has pressured growth equities, yet cybersecurity ETFs are delivering relative steadiness as co...
A working-class manager confronts a debt trap after purchasing a costly vehicle on a modest salary, underscoring how ...
A public-school principal with a large retirement nest egg discovers her MAGI pushes her Medicare premiums into a hig...
A debt-heavy aging couple illustrates how disagreement between spouses can delay retirement, underscoring dave ramsey...
A bold government push is reshaping quantum tech and investing. Learn which three big stocks are positioned to win, a...
Oil prices hover around $75 per barrel on June 29, 2026 as markets digest supply and demand signals. This briefing ex...
A Chinese regulator warned of a security backdoor in Anthropic's Claude Code, signaling tightened AI-tool oversight a...
A new move from Google signals a shift in AI compute. This could tilt the balance away from Nvidia in certain cloud a...